Deliverable transgenics & gene therapy possibilities for the testes.
Mol Cell Endocrinol
; 468: 81-94, 2018 06 15.
Article
en En
| MEDLINE
| ID: mdl-29191697
ABSTRACT
Male infertility and hypogonadism are clinically prevalent conditions with a high socioeconomic burden and are both linked to an increased risk in cardiovascular-metabolic diseases and earlier mortality. Therefore, there is an urgent need to better understand the causes and develop new treatments for these conditions that affect millions of men. The accelerating advancement in gene editing and delivery technologies promises improvements in both diagnosis as well as affording the opportunity to develop bespoke treatment options which would both prove beneficial for the millions of individuals afflicted with these reproductive disorders. In this review, we summarise the systems developed and utilised for the delivery of gene therapy and discuss how each of these systems could be applied for the development of a gene therapy system in the testis and how they could be of use for the future diagnosis and repair of common male reproductive disorders.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Testículo
/
Terapia Genética
/
Técnicas de Transferencia de Gen
/
Transgenes
Límite:
Animals
/
Humans
/
Male
Idioma:
En
Revista:
Mol Cell Endocrinol
Año:
2018
Tipo del documento:
Article
País de afiliación:
Reino Unido